Ectopic lymphoid follicles: Inducible centres for generating antigen-specific immune responses within tissues

Immunology

Volumn 147, Issue 2, 2016, Pages 141-151

  Jones, Gareth W ^a   Jones, Simon A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Arthritis; Autoimmunity; Cancer; Infection; Lymphoid neogenesis

Indexed keywords

CHEMOKINE; CYTOKINE; AUTACOID; AUTOANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHRONIC DISEASE; ECTOPIC TISSUE; HISTOCOMPATIBILITY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; LYMPH FOLLICLE; LYMPHANGIOGENESIS; LYMPHOID ORGAN; MOLECULAR MECHANICS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; ANIMAL; CHORISTOMA; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; SIGNAL TRANSDUCTION; TUMOR ESCAPE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CHORISTOMA; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LYMPHOID TISSUE; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 84956648198     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12554     Document Type: Article

References (152)

1. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006; 7:344-53.
2. Kurashima Y, Goto Y, Kiyono H. Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation. Eur J Immunol 2013; 43:3108-15.
3. Roozendaal R, Mebius RE. Stromal cell-immune cell interactions. Annu Rev Immunol 2011; 29:23-43.
4. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428-35.
5. Buckley CD. Why does chronic inflammation persist: an unexpected role for fibroblasts. Immunol Lett 2011; 138:12-4.
6. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005; 175:3463-8.
7. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7:429-42.
8. Choy EH, Kavanaugh AF, Jones SA. The problem of choice: current biologic agents and future prospects in RA. Nat Rev Rheumatol 2013; 9:154-63.
9. Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH. Tertiary lymphoid structures in cancer and beyond. Trends Immunol 2014; 35:571-80.
10. Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 2014; 14:447-62.
11. Pitzalis C, Kelly S, Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol 2013; 25:334-44.
12. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010; 10:664-74.
13. Peduto L, Dulauroy S, Lochner M, Spath GF, Morales MA, Cumano A et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol 2009; 182:5789-99.
14. Vondenhoff MF, Greuter M, Goverse G, Elewaut D, Dewint P, Ware CF et al. LTβR signaling induces cytokine expression and up-regulates lymphangiogenic factors in lymph node anlagen. J Immunol 2009; 182:5439-45.
15. Jarjour M, Jorquera A, Mondor I, Wienert S, Narang P, Coles MC et al. Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells. J Exp Med 2014; 211:1109-22.
16. Katakai T. Marginal reticular cells: a stromal subset directly descended from the lymphoid tissue organizer. Front Immunol 2012; 3:200.
17. Grogan JL, Ouyang W. A role for Th17 cells in the regulation of tertiary lymphoid follicles. Eur J Immunol 2012; 42:2255-62.
18. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011; 12:639-46.
19. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 2011; 35:986-96.
20. Benezech C, Nayar S, Finney BA, Withers DR, Lowe K, Desanti GE et al. CLEC-2 is required for development and maintenance of lymph nodes. Blood 2014; 123:3200-7.
21. Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med 2015; 212:1793-802.
22. Canete JD, Celis R, Yeremenko N, Sanmarti R, van Duivenvoorde L, Ramirez J et al. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arthritis Res Ther 2015; 17:173.
23. Barone F, Nayar S, Campos J, Cloake T, Withers DR, Toellner KM et al. IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs. Proc Natl Acad Sci USA 2015; 112:11024-9.
24. Chaitanya GV, Omura S, Sato F, Martinez NE, Minagar A, Ramanathan M et al. Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature. J Neuroinflammation 2013; 10:125.
25. Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, Dubois V et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010; 184:5344-51.
26. + innate lymphoid cells. Science 2010; 330:665-9.
27. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206:35-41.
28. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011; 34:122-34.
29. Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210:917-31.
30. Artis D, Spits H. The biology of innate lymphoid cells. Nature 2015; 517:293-301.
31. + lymphoid tissue inducer cells. J Immunol 2009; 183:2217-21.
32. Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, Ceredig R et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007; 26:643-54.
33. Fleige H, Ravens S, Moschovakis GL, Bolter J, Willenzon S, Sutter G et al. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J Exp Med 2014; 211:643-51.
34. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000; 192:1545-52.
35. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192:1553-62.
36. Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM et al. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol 2013; 14:372-9.
37. Lu KT, Kanno Y, Cannons JL, Handon R, Bible P, Elkahloun AG et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 2011; 35:622-32.
38. Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu KT, Johnson TA et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011; 35:919-31.
39. Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, De Vita S et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 2008; 180:5130-40.
40. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall TD. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 2007; 104:10577-82.
41. Sato M, Hirayama S, Matsuda Y, Wagnetz D, Hwang DM, Guan Z et al. Stromal activation and formation of lymphoid-like stroma in chronic lung allograft dysfunction. Transplantation 2011; 91:1398-405.
42. Braun A, Takemura S, Vallejo AN, Goronzy JJ, Weyand CM. Lymphotoxin β-mediated stimulation of synoviocytes in rheumatoid arthritis. Arthritis Rheum 2004; 50:2140-50.
43. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001; 167:1072-80.
44. Timmer TC, Baltus B, Vondenhoff M, Huizinga TW, Tak PP, Verweij CL et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 2007; 56:2492-502.
45. Bombardieri M, Kam NW, Brentano F, Choi K, Filer A, Kyburz D et al. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis 2011; 70:1857-65.
46. Benezech C, White A, Mader E, Serre K, Parnell S, Pfeffer K et al. Ontogeny of stromal organizer cells during lymph node development. J Immunol 2010; 184:4521-30.
47. van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, Beke P et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol 2009; 10:1193-9.
48. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002; 169:424-33.
49. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000; 12:471-81.
50. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000; 406:309-14.
51. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004; 5:943-52.
52. Luther SA, Ansel KM, Cyster JG. Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J Exp Med 2003; 197:1191-8.
53. Ohl L, Henning G, Krautwald S, Lipp M, Hardtke S, Bernhardt G et al. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J Exp Med 2003; 197:1199-204.
54. Chen SC, Vassileva G, Kinsley D, Holzmann S, Manfra D, Wiekowski MT et al. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 2002; 168:1001-8.
55. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 2000; 164:3955-9.
56. Christopherson KW 2nd, Hood AF, Travers JB, Ramsey H, Hromas RA. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood 2003; 101:801-6.
57. Weninger W, Carlsen HS, Goodarzi M, Moazed F, Crowley MA, Baekkevold ES et al. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003; 170:4638-48.
58. Baddoura FK, Nasr IW, Wrobel B, Li Q, Ruddle NH, Lakkis FG. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005; 5:510-6.
59. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005; 52:1773-84.
60. Bento DC, Jones E, Junaid S, Tull J, Williams GT, Godkin A et al. High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression. Oncoimmunology 2015; 4:e974374.
61. Canete JD, Santiago B, Cantaert T, Sanmarti R, Palacin A, Celis R et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis 2007; 66:720-6.
62. Cipponi A, Mercier M, Seremet T, Baurain JF, Theate I, van den Oord J et al. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res 2012; 72:3997-4007.
63. Manzo A, Bugatti S, Caporali R, Prevo R, Jackson DG, Uguccioni M et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol 2007; 171:1549-62.
64. Weiss JM, Cufi P, Bismuth J, Eymard B, Fadel E, Berrih-Aknin S et al. SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. Immunobiology 2013; 218:373-81.
65. Hindley JP, Jones E, Smart K, Bridgeman H, Lauder SN, Ondondo B et al. T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res 2012; 72:5473-82.
66. Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard JP. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer. J Immunol 2013; 191:2001-8.
67. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71:5678-87.
68. Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011; 479:542-6.
69. Onder L, Danuser R, Scandella E, Firner S, Chai Q, Hehlgans T et al. Endothelial cell-specific lymphotoxin-beta receptor signaling is critical for lymph node and high endothelial venule formation. J Exp Med 2013; 210:465-73.
70. Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P et al. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. Oncoimmunology 2012; 1:829-39.
71. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306.
72. Schrama D, Voigt H, Eggert AO, Xiang R, Zhou H, Schumacher TN et al. Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue. Cancer Immunol Immunother 2008; 57:85-95.
73. Schrama D, thor Straten P, Fischer WH, McLellan AD, Brocker EB, Reisfeld RA et al. Targeting of lymphotoxin-α to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14:111-21.
74. Peske JD, Thompson ED, Gemta L, Baylis RA, Fu YX, Engelhard VH. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun 2015; 6:7114.
75. Lucchesi D, Bombardieri M. The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases. J Leukoc Biol 2013; 94:1191-9.
76. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 2012; 33:297-305.
77. Khader SA, Rangel-Moreno J, Fountain JJ, Martino CA, Reiley WW, Pearl JE et al. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol 2009; 183:8004-14.
78. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999; 104:R49-54.
79. + T helper cells mediate protective immunity against tuberculosis. J Clin Invest 2013; 123:712-26.
80. GeurtsvanKessel CH, Willart MA, Bergen IM, van Rijt LS, Muskens F, Elewaut D et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009; 206:2339-49.
81. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, Kusser K, Tighe MP, Klonowski KD et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 2006; 25:643-54.
82. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004; 10:927-34.
83. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160:3594-601.
84. Sansonno D, Tucci FA, Troiani L, Lauletta G, Montrone M, Conteduca V et al. Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. Blood 2008; 112:1620-7.
85. Grewal JS, Pilgrim MJ, Grewal S, Kasman L, Werner P, Bruorton ME et al. Salivary glands act as mucosal inductive sites via the formation of ectopic germinal centers after site-restricted MCMV infection. FASEB J 2011; 25:1680-96.
86. Lochner M, Ohnmacht C, Presley L, Bruhns P, Si-Tahar M, Sawa S et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells. J Exp Med 2011; 208:125-34.
87. Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 2012; 12:237-51.
88. Bergomas F, Grizzi F, Doni A, Pesce S, Laghi L, Allavena P et al. Tertiary intratumor lymphoid tissue in colo-rectal cancer. Cancers (Basel) 2011; 4:1-10.
89. McMullen TP, Lai R, Dabbagh L, Wallace TM, de Gara CJ. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules. Clin Exp Immunol 2010; 161:81-8.
90. + follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 2013; 123:2873-92.
91. Nzula S, Going JJ, Stott DI. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 2003; 63:3275-80.
92. + T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 2012; 18:3281-92.
93. Willis SN, Mallozzi SS, Rodig SJ, Cronk KM, McArdel SL, Caron T et al. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J Immunol 2009; 182:3310-7.
94. + mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 2007; 56:1459-69.
95. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26:4410-7.
96. Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 2014; 189:832-44.
97. + T cells. Cancer Res 2014; 74:705-15.
98. Remark R, Alifano M, Cremer I, Lupo A, Dieu-Nosjean MC, Riquet M et al. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res 2013; 19:4079-91.
99. Kirk CJ, Hartigan-O'Connor D, Mule JJ. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res 2001; 61:8794-802.
100. Joshi NS, Akama-Garren EH, Lu Y, Lee DY, Chang GP, Li A et al. Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses. Immunity 2015; 43:579-90.
101. Klimiuk PA, Goronzy JJ, Bjornsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997; 151:1311-9.
102. Manzo A, Bombardieri M, Humby F, Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol Rev 2010; 233:267-85.
103. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J Clin Invest 1998; 102:938-46.
104. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130:1089-104.
105. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 1998; 188:1493-501.
106. Houtkamp MA, de Boer OJ, van der Loos CM, van der Wal AC, Becker AE. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol 2001; 193:263-9.
107. Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors. Immunity 2015; 42:1100-15.
108. Carlsen HS, Baekkevold ES, Johansen FE, Haraldsen G, Brandtzaeg P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 2002; 51:364-71.
109. Surawicz CM, Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 1984; 86:104-13.
110. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-53.
111. Van Pottelberge GR, Bracke KR, Van den Broeck S, Reinartz SM, van Drunen CM, Wouters EF et al. Plasmacytoid dendritic cells in pulmonary lymphoid follicles of patients with COPD. Eur Respir J 2010; 36:781-91.
112. Canete JD, Celis R, Moll C, Izquierdo E, Marsal S, Sanmarti R et al. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor α therapy in rheumatoid arthritis. Ann Rheum Dis 2009; 68:751-6.
113. Thurlings RM, Wijbrandts CA, Mebius RE, Cantaert T, Dinant HJ, van der Pouw-Kraan TC et al. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum 2008; 58:1582-9.
114. Manzo A, Paoletti S, Carulli M, Blades MC, Barone F, Yanni G et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 2005; 35:1347-59.
115. Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE et al. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 2001; 166:650-5.
116. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009; 6:e1.
117. Rosengren S, Wei N, Kalunian KC, Zvaifler NJ, Kavanaugh A, Boyle DL. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab. Arthritis Res Ther 2008; 10:R105.
118. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001; 167:4710-8.
119. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7:R949-58.
120. Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani-Matsuda M, Mekki Y et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 2010; 185:717-28.
121. Brown K, Sacks SH, Wong W. Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. Eur J Immunol 2011; 41:89-96.
122. Le Texier L, Thebault P, Lavault A, Usal C, Merieau E, Quillard T et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011; 11:429-38.
123. -/- mice. J Exp Med 2009; 206:233-48.
124. Thaunat O, Patey N, Gautreau C, Lechaton S, Fremeaux-Bacchi V, Dieu-Nosjean MC et al. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 2008; 85:1648-53.
125. Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol 2015; 16:448-57.
126. Fava RA, Kennedy SM, Wood SG, Bolstad AI, Bienkowska J, Papandile A et al. Lymphotoxin-β receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjogren's syndrome. Arthritis Res Ther 2011; 13:R182.
127. Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A et al. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 2003; 171:115-26.
128. Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI. Blockade of lymphotoxin-β receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther 2009; 11:R24.
129. Lee Y, Chin RK, Christiansen P, Sun Y, Tumanov AV, Wang J et al. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure. Immunity 2006; 25:499-509.
130. Henry RA, Kendall PL. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice. J Immunol 2010; 185:1460-5.
131. Kramer JM, Klimatcheva E, Rothstein TL. CXCL13 is elevated in Sjogren's syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol 2013; 94:1079-89.
132. Zheng B, Ozen Z, Zhang X, De Silva S, Marinova E, Guo L et al. CXCL13 neutralization reduces the severity of collagen-induced arthritis. Arthritis Rheum 2005; 52:620-6.
133. Bucher C, Koch L, Vogtenhuber C, Goren E, Munger M, Panoskaltsis-Mortari A et al. IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation. Blood 2009; 114:5375-84.
134. Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 2007; 178:3822-30.
135. Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L et al. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 2007; 56:1152-63.
136. Foo SY, Zhang V, Lalwani A, Lynch JP, Zhuang A, Lam CE et al. Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation. J Immunol 2015; 194:4567-76.
137. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008; 29:138-49.
138. Goya S, Matsuoka H, Mori M, Morishita H, Kida H, Kobashi Y et al. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J Pathol 2003; 200:82-7.
139. H17 cells. Nature 2007; 448:484-7.
140. Bombardieri M, Barone F, Lucchesi D, Nayar S, van den Berg WB, Proctor G et al. Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol 2012; 189:3767-76.
141. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185:2143-56.
142. Nacionales DC, Kelly KM, Lee PY, Zhuang H, Li Y, Weinstein JS et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2 #bib6 #bib10 #bib14-tetramethyl-pentadecane (pristane). Am J Pathol 2006; 168:1227-40.
143. Ray JP, Marshall HD, Laidlaw BJ, Staron MM, Kaech SM, Craft J. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity 2014; 40:367-77.
144. Esen N, Rainey-Barger EK, Huber AK, Blakely PK, Irani DN. Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Glia 2014; 62:1452-62.
145. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-40.
146. Batten M, Ramamoorthi N, Kljavin NM, Ma CS, Cox JH, Dengler HS et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med 2010; 207:2895-906.
147. + T cells. Eur J Immunol 2013; 43:1063-73.
148. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006; 7:937-45.
149. Lee BH, Carcamo WC, Chiorini JA, Peck AB, Nguyen CQ. Gene therapy using IL-27 ameliorates Sjogren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther 2012; 14:R172.
150. Ballesteros-Tato A, Leon B, Graf BA, Moquin A, Adams PS, Lund FE et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 2012; 36:847-56.
151. Johnston RJ, Choi YS, Diamond JA, Yang JA, Crotty S. STAT5 is a potent negative regulator of TFH cell differentiation. J Exp Med 2012; 209:243-50.
152. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26:371-81.